GL1X · GenesisL1 explorer

MolNFT v1 · #27613 · protein

Catalytic domain of human phosphodiesterase 5A in complex with vardenafil

1XP0 · Cgmp-specific 3',5'-cyclic phosphodiesterase: “Catalytic domain of human phosphodiesterase 5A in complex with vardenafil”. X-ray diffraction, 3 ligands (VDN, ZN, MG), 3 pockets (best druggability 0.72). MolNFT v1 #27613 on…

PDB
1XP0
Type
protein
Length
326 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cgmp-specific 3',5'-cyclic phosphodiesterase
EC
3.1.4.17
UniProt
O76074
Ligands
VDN, ZN, MG
Pockets
3 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 72% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACgmp-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.17)protein32672% helix, 0% strandO76074

Ligands and binding sites

  • VDN · 2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one · ligand · chains A
  • ZN · Zinc ion · metal · chains A
  • MG · Magnesium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14290.720.8239MG, VDN
2660.510.8621empty
3530.330.7810empty

Compared structures

  • 1XP0 · Catalytic Domain Of Human Phosphodiesterase 5A In Complex With Vardenafil · the same entry in another collection · chain A against A, TM-score 1.00
  • O76074 · AlphaFold monomer V2.0 prediction for cgmp-specific 3',5'-cyclic phosphodiesterase… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.